Tenofovir alafenamide for HIV: time to switch?
Lancet Infect Dis
.
2016 Jan;16(1):3-5.
doi: 10.1016/S1473-3099(15)00412-0.
Epub 2015 Nov 2.
Authors
Shireesha Dhanireddy
1
,
Jared M Baeten
2
Affiliations
1
Department of Medicine, University of Washington, Seattle, WA 98104, USA.
2
Departments of Global Health, Medicine, and Epidemiology, University of Washington, Seattle, WA 98104, USA. Electronic address:
[email protected]
.
PMID:
26538524
DOI:
10.1016/S1473-3099(15)00412-0
No abstract available
Publication types
Comment
MeSH terms
Adenine / analogs & derivatives*
Anti-HIV Agents / therapeutic use*
Female
HIV Infections / drug therapy*
HIV-1*
Humans
Male
Tenofovir / therapeutic use*
Substances
Anti-HIV Agents
Tenofovir
Adenine